CVS Caremark Corporation, the second-largest drugstore chain in the U.S., plans to acquire the Medicare Prescription Drug business of Universal American for about $1.25 billion.
CVS Caremark Corporation, the second-largest drugstore chain in the U.S., plans to acquire the Medicare Prescription Drug business of Universal American for about $1.25 billion.
CVS Caremark will acquire all of the outstanding stock of Universal American and distribute the shares of a newly formed public company to Universal American shareholders. The new company will own all other operations of Universal American, including its Medicare Advantage and Traditional Insurance businesses.
According to the Los Angeles Times, the size of CVS Caremark's business that provides prescription drug coverage under the Medicare Part D program will more than double because of the deal.
Medco Health Solutions, Inc.'s Medicare Part D prescription benefits management agreement with MemberHealth, LLC, a subsidiary of Universal American, has been terminated as a result of the CVS Caremark acquisition announcement. Medco provides pharmacy benefit management services to beneficiaries of various Medicare plans that are under contract with the Centers for Medicare and Medicaid Services.
"Universal American will now focus its energies on overcoming our regulatory challenges and building momentum in the Medicare Advantage business to take advantage of our Healthy Collaboration approach to healthcare," said Richard Barasch, chairman and CEO of Universal American, in a press statement.
The transaction is expected to close by the end of the second quarter of 2011 and is subject to customary closing conditions.
New Guidance for Managing People With Acute Kidney Injury Requiring Outpatient Dialysis
March 14th 2025Patients with acute kidney injury requiring temporary hemodialysis often follow the protocol used for people on long-term dialysis, despite significant pathophysiological differences between the two.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Where Are They Now? Lissy Hu Joins Ascend to Tackle Workforce Challenges
March 14th 2025Lissy Hu, M.D., MBA, CEO of Ascend Learning, was one of Managed Healthcare Executive’s 2022 Emerging Leaders in Healthcare winners. The editors caught up with Hu as part of our new “Where Are They Now?” series spotlighting the career paths of past emerging leaders.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 14th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More